Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer ; volume:31 ; number:10 ; day:20 ; month:9 ; year:2023 ; pages:1-10 ; date:10.2023
Supportive care in cancer ; 31, Heft 10 (20.9.2023), 1-10, 10.2023
- Urheber
-
Aapro, Matti S.
Chaplin, Stephen
Cornes, Paul
Howe, Sebastian
Link, Hartmut
Koptelova, Natalia
Mehl, Andrea
Palma, Mario Di
Schroader, Bridgette Kanz
Terkola, Robert
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-023-08043-4
- URN
-
urn:nbn:de:101:1-2024010809033516933216
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Aapro, Matti S.
- Chaplin, Stephen
- Cornes, Paul
- Howe, Sebastian
- Link, Hartmut
- Koptelova, Natalia
- Mehl, Andrea
- Palma, Mario Di
- Schroader, Bridgette Kanz
- Terkola, Robert
- SpringerLink (Online service)
Ähnliche Objekte (12)
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer
Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
Correction to: Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Aggressive Recurrent Pancreatic Cancer Producing Granulocyte Colony-Stimulating Factor
Semisynthesis of Homogeneous, Active Granulocyte Colony‐Stimulating Factor Glycoforms
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials
Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?
Role of granulocyte colony-stimulating factor in infection and inflammation
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer
Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
Correction to: Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Aggressive Recurrent Pancreatic Cancer Producing Granulocyte Colony-Stimulating Factor
Semisynthesis of Homogeneous, Active Granulocyte Colony‐Stimulating Factor Glycoforms
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials
Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?
Role of granulocyte colony-stimulating factor in infection and inflammation
Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
Granulocyte Colony-Stimulating Factor-Producing Bladder Cancer
Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice
Correction to: Systematic Review and Meta-analysis of Short-versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
Aggressive Recurrent Pancreatic Cancer Producing Granulocyte Colony-Stimulating Factor
Semisynthesis of Homogeneous, Active Granulocyte Colony‐Stimulating Factor Glycoforms
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials
Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?